"Etablissement de santé multidisciplinaire disposant d'un plateau technique complet (IRM, Scanner, Urgences,....) Certification A HAS 1er établissement en traitement de l'incontinence urinaire de France 1er établissement en cancérologie de l'Oise 1er établissement en chirurgie de l'Obésité des Hauts de France 1er établissement de chirurgie ambulatoire de l'Oise Centre spécialisé - traitement Maladie de Lyme Maternité IHAB Dialyse, Soins de Suite, Soins Intensifs, Médecine Polyvalente Radiothérapie Balnéothérapie Programmes d’Education Thérapeutique en cancer, obésité et dialyse"

During the past decade, Polyclinique Saint come conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Polyclinique Saint come" #1 sponsor was "Federation Francophone de Cancerologie Digestive" with 6 trials, followed by "Centre Hospitalier Universitaire, Amiens" with 2 trials sponsored, "Association Pour La Recherche des Thérapeutiques Innovantes en Cancérologie" with 1 trials sponsored, "Centre Hospitalier Universitaire de Nice" with 1 trials sponsored and "Floralis" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Polyclinique Saint come" #1 collaborator was "GERCOR - Multidisciplinary Oncology Cooperative Group" with 2 trials as a collaborator, "ARCAGY/ GINECO GROUP" with 1 trials as a collaborator, "Association de Neuro-Oncologues d'Expression Francaise" with 1 trials as a collaborator, "Centre Hospitalier Universitaire, Amiens" with 1 trials as a collaborator and "Centre de traitement des données du Cancéropôle Nord-Ouest, Centre F. BACLESSE, Caen, France" with 1 trials as a collaborator. Other collaborators include 4 different institutions and companies that were collaborators in the rest 14 trials.

According to Clinical.Site data, the most researched conditions in "Polyclinique Saint come" are "Cancer" (2 trials), "Surgery" (2 trials), "COVID" (1 trials), "Chemotherapy" (1 trials) and "Clinical Research" (1 trials). Many other conditions were trialed in "Polyclinique Saint come" in a lesser frequency.

Most popular intervention types in "Polyclinique Saint come" are "Drug" (6 trials), "Other" (2 trials), "Procedure" (2 trials) and "Behavioral" (1 trials). Other intervention types were less common.

The name of intervention was led by "Bevacizumab" (3 trials), "Oxaliplatin" (2 trials), "Panitumumab" (2 trials), "5 FU bolus" (1 trials) and "5 FU continuous" (1 trials). Other intervention names were less common.

The vast majority of trials in "Polyclinique Saint come" are 11 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Polyclinique Saint come". undefined are not yet recruiting, 5 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Polyclinique Saint come, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Polyclinique Saint come, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".